12:53 PM
 | 
Jul 13, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

I-Mab raises $220M in series C

I-Mab Biopharma (Shanghai, China) raised $220 million June 29 in a series C round led by Hony Capital, making it at least the fourth $200 million-plus VC round led by Chinese investors in the past two months.

Also participating in I-Mab’s round were Hillhouse Capital, HOPU Investments,...

Read the full 213 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >